Dr. Arron is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1750 El Camino Real Ste 206
Burlingame, CA 94010Phone+1 650-692-0182Fax+1 415-353-7838
Education & Training
- University of California (San Francisco)Residency, Dermatology, 2004 - 2006
- Santa Clara Valley Medical CenterInternship, Transitional Year, 2003 - 2004
- Weill Cornell MedicineClass of 2003
Certifications & Licensure
- CA State Medical License 2004 - 2026
- American Board of Dermatology Dermatology
- American Board of Preventive Medicine Clinical Informatics
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012
- Fellow (FAAD) American Academy of Dermatology
- Fellow (FASDS) American Society for Dermatologic Surgery
Clinical Trials
- Phase II Study of Radiation Therapy and Vismodegib for Advanced Head/Neck Basal Cell Carcinoma Start of enrollment: 2013 May 01
- Daylight Photodynamic Therapy for Actinic Keratosis Start of enrollment: 2017 Dec 01
- An Open-label Study Using ASP-1929 Photoimmunotherapy in Combination With Anti-PD1 Therapy in EGFR Expressing Advanced Solid Tumors Start of enrollment: 2020 Dec 21
Publications & Presentations
PubMed
- 55 citationsRegulatory T cells use arginase 2 to enhance their metabolic fitness in tissuesMargaret M. Lowe, Ian C. Boothby, Sean Clancy, Richard Ahn, Wilson Liao
JCI Insight. 2019-12-19 - 1139 citationsCancer-Associated Fibroblasts Are Activated in Incipient Neoplasia to Orchestrate Tumor-Promoting Inflammation in an NF-κB-Dependent MannerNeta Erez, Morgan L. Truitt, Peter Olson, Sarah T. Arron, Douglas Hanahan
Cancer Cell. 2010-02-17 - 64 citationsFitzpatrick skin phototype is an independent predictor of squamous cell carcinoma risk after solid organ transplantationRavinder Gogia, M. Binstock, Ryutaro Hirose, W. John Boscardin, Mary-Margaret Chren
Journal of the American Academy of Dermatology. 2013-04-01
Journal Articles
- Voriconazole and the Risk of Keratinocyte Carcinomas Among Lung Transplant Recipients in the United StatesSarah T Arron, Isaac Brownell, Matthew A Triplette, Eric A Engels, JAMA Dermatology
- Characteristics and Skin Cancer Risk Behaviors of Adult Sunless Tanners in the United StatesMatthew D Mansh, Eleni Linos, Ingrid Polcari, Sarah T Arron, JAMA
Authored Content
- Voriconazole and the Risk of Keratinocyte Carcinomas Among Lung Transplant Recipients in the United StatesMay 2020
- Voriconazole and the Risk of Keratinocyte Carcinomas Among Lung Transplant Recipients in the United StatesMay 2020
Press Mentions
- Castle Biosciences to Present Data Supporting the Clinical Value of Its Suite of Skin Cancer Tests Through Multiple Oral Presentations at the 2022 American Society for Dermatologic Surgery (ASDS) Annual MeetingOctober 10th, 2022
- Study Finds Higher Risk of Skin Cancer After Childhood Organ TransplantJune 28th, 2022
- Data from Second Independent Multi-Center Study of Patients with High-Risk Cutaneous Squamous Cell Carcinoma Confirms Independent Risk-Stratification Performance of DecisionDx®-SCCMay 19th, 2022
- Join now to see all
Professional Memberships
- Fellow
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: